Technical Analysis for 0QLR - Novartis AG
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | -0.55% | |
| Narrow Range Bar | Range Contraction | -0.55% | |
| Upper Bollinger Band Walk | Strength | -0.55% | |
| Above Upper BB | Strength | -0.55% | |
| Up 3 Days in a Row | Strength | -0.55% | |
| Up 4 Days in a Row | Strength | -0.55% | |
| Up 5 Days in a Row | Strength | -0.55% | |
| Multiple of Ten Bearish | Other | 0.26% |
Get this analysis on your stocks daily!
Novartis AG Description
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 94.6222 |
| 52 Week Low | 83.115 |
| Average Volume | 88,860 |
| 200-Day Moving Average | 88.22 |
| 50-Day Moving Average | 87.78 |
| 20-Day Moving Average | 86.82 |
| 10-Day Moving Average | 87.12 |
| Average True Range | 1.37 |
| RSI (14) | 63.64 |
| ADX | 23.23 |
| +DI | 37.42 |
| -DI | 19.45 |
| Chandelier Exit (Long, 3 ATRs) | 87.68 |
| Chandelier Exit (Short, 3 ATRs) | 88.11 |
| Upper Bollinger Bands | 90.39 |
| Lower Bollinger Band | 83.24 |
| Percent B (%b) | 0.95 |
| BandWidth | 8.23 |
| MACD Line | 0.47 |
| MACD Signal Line | -0.17 |
| MACD Histogram | 0.6438 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 91.06 | ||||
| Resistance 3 (R3) | 90.94 | 90.47 | 90.88 | ||
| Resistance 2 (R2) | 90.47 | 90.20 | 90.53 | 90.82 | |
| Resistance 1 (R1) | 90.24 | 90.03 | 90.35 | 90.35 | 90.76 |
| Pivot Point | 89.77 | 89.77 | 89.82 | 89.82 | 89.77 |
| Support 1 (S1) | 89.53 | 89.50 | 89.65 | 89.65 | 89.24 |
| Support 2 (S2) | 89.06 | 89.33 | 89.12 | 89.18 | |
| Support 3 (S3) | 88.83 | 89.06 | 89.12 | ||
| Support 4 (S4) | 88.94 |
